Oakmark Concentrated Strategy Adds Marsh & McLennan as New Position

Insider Monkey··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Oakmark U.S. Concentrated Strategy initiated a new position in Marsh & McLennan Companies during the second quarter of 2026. The firm views the world's largest insurance broker as a leader in an oligopolistic market with strong organic revenue growth and consistent margin expansion. Management's rebranding efforts include an expense program, leveraging AI to improve productivity, and centralizing technology and operations to drive efficiencies. The stock has fallen out of favor due to softening insurance rates and macroeconomic uncertainty, which Oakmark sees as an opportunity to invest at an attractive price. Marsh & McLennan closed at $192.19 per share on July 28, 2026, with a market capitalization of $91.72 billion.

Impact on assets 1

Financials▲ · 1 stocks